LIVE/VIRTUAL ACTIVITIES

Bio Ascend – Designing CME Solutions For a Virtual World, Our Live and Virtual CME Activities Are Designed to Keep HCPs Educated.

Bio Ascend helps healthcare providers (HCPs) like you stay educated by providing the CME resources you need for continuing education. Our vast selection of activities is devoted entirely to solid tumor and hematologic malignancies – with engaging options in both in-person and virtual environments. Activities feature leading experts discussing the latest data and how to apply it to clinical practice, providing you with critical insight and direction on how to incorporate therapeutic advancements into your practice.

Satellite Symposia:
Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma

September 10, 2021 – Live/Virtual
Time: 6:15 AM – 7:45 AM CDT

This live satellite symposium will take place in conjunction with the 2021 Society of Hematologic Oncology Annual Meeting and will be presented by three renowned experts actively engaged in the care of patients with relapsed/refractory multiple myeloma. This symposium will also be live-streamed for those who may not be able to attend in person.

Be sure to check back in October to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Not an official program of the SOHO 2021 Annual Meeting. Not sponsored or endorsed by the Society of Hematologic Oncology.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Thomas Martin, MD
University of California San Francisco

Krina Patel, MD, MSc
UT MD Anderson Cancer Center

Satellite Symposia:
Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma

September 10, 2021 – Live/Virtual
Time: 6:15 AM – 7:45 AM CDT

This live satellite symposium will take place in conjunction with the 2021 Society of Hematologic Oncology Annual Meeting and will be presented by three renowned experts actively engaged in the care of patients with relapsed/refractory multiple myeloma. This symposium will also be live-streamed for those who may not be able to attend in person.

Be sure to check back in October to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Not an official program of the SOHO 2021 Annual Meeting. Not sponsored or endorsed by the Society of Hematologic Oncology.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Thomas Martin, MD
University of California San Francisco

Krina Patel, MD, MSc
UT MD Anderson Cancer Center

Satellite Symposia:
Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies

August 11, 2021 – Live/Virtual
Time: 1:00 PM – 3:00 PM HST (4 PM PT/6 PM CT/7 PM ET)

This live symposium on The Treatment of Patients with Hematologic Malignancies will be presented at #PPLC21 and feature expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma.

Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Not attending #PPLC21 in-person? Don’t worry, live stream opportunities will be available.

Symposium Chair

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Faculty

Tara Graff, DO, MS
Mission Cancer and Blood
Des Moines, Iowa

Nina Shah, MD
Associate Professor, Department of Medicine
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

Satellite Symposia:
Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies

August 11, 2021 – Live/Virtual
Time: 1:00 PM – 3:00 PM HST (4 PM PT/6 PM CT/7 PM ET)

This live symposium on The Treatment of Patients with Hematologic Malignancies will be presented at #PPLC21 and feature expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma.

Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Not attending #PPLC21 in-person? Don’t worry, live stream opportunities will be available.

Symposium Chair

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Faculty

Tara Graff, DO, MS
Mission Cancer and Blood
Des Moines, Iowa

Nina Shah, MD
Associate Professor, Department of Medicine
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

Satellite Symposia:
Expert Tumor Board to Address Challenging Cases of Relapsed/Refractory Aggressive and Indolent Lymphomas

August 9, 2021 – Live/Virtual
Time: 3:00 PM – 5:00 PM HST (6 PM PT/8 PM CT/9 PM ET)

This live symposium on Aggressive and Indolent Lymphomas will be presented at #PPLC21. This interactive symposium will provide expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with various aggressive and indolent lymphoma subtypes.

Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Not attending #PPLC21 in-person? Don’t worry, live stream opportunities will be available.

Symposium Chair

Matthew Lunning, DO, FACP
University of Nebraska Medical Center

Faculty

Ranjana Advani, MD
Stanford Cancer Institute­

Andrew Zelenetz, MD, PhD­
Memorial Sloan Kettering Cancer
Weill Cornell Medicine­

Satellite Symposia: Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies

August 9, 2021 – Live/Virtual
Time: 3:00 PM – 5:00 PM HST (6 PM PT/8 PM CT/9 PM ET)

This live symposium on Aggressive and Indolent Lymphomas will be presented at #PPLC21. This interactive symposium will provide expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with various aggressive and indolent lymphoma subtypes.

Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Not attending #PPLC21 in-person? Don’t worry, live stream opportunities will be available.

Symposium Chair

Matthew Lunning, DO, FACP
University of Nebraska Medical Center

Faculty

Ranjana Advani, MD
Stanford Cancer Institute­

Andrew Zelenetz, MD, PhD­
Memorial Sloan Kettering Cancer
Weill Cornell Medicine­

Satellite Symposia:
Expert Tumor Board to Address Challenging Cases of Relapsed/Refractory Aggressive and Indolent Lymphomas

August 9, 2021 – Live/Virtual
Time: 3:00 PM – 5:00 PM HST (6 PM PT/8 PM CT/9 PM ET)

This live symposium on Aggressive and Indolent Lymphomas will be presented at #PPLC21. This interactive symposium will provide expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with various aggressive and indolent lymphoma subtypes.

Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Not attending #PPLC21 in-person? Don’t worry, live stream opportunities will be available.

Symposium Chair

Matthew Lunning, DO, FACP
University of Nebraska Medical Center

Faculty

Ranjana Advani, MD
Stanford Cancer Institute­

Andrew Zelenetz, MD, PhD­
Memorial Sloan Kettering Cancer
Weill Cornell Medicine­

Satellite Symposia:
New Targets, New Agents, New Combinations: Navigating the New Landscape in Relapsed/Refractory Multiple Myeloma

June 15, 2021 – Virtual
Time: 7:00 PM – 8:45 PM EDT

This live-streamed independent satellite symposium will take place following the #ASCO21 Meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the care of patients with multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Symposium Chair

Noopur Raje, MD Massachusetts General Hospital

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP
Translational Genomics Research Institute (TGen), City of Hope Cancer Center
International Myeloma Foundation

Krina Patel, MD, MSc
The University of Texas
MD Anderson Cancer Center

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Satellite Symposia:
New Targets, New Agents, New Combinations: Navigating the New Landscape in Relapsed/Refractory Multiple Myeloma

June 15, 2021 – Virtual
Time: 7:00 PM – 8:45 PM EDT

This live-streamed independent satellite symposium will take place following the #ASCO21 Meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the care of patients with multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Symposium Chair

Noopur Raje, MD
Massachusetts General Hospital

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP
Translational Genomics Research Institute (TGen), City of Hope Cancer Center
International Myeloma Foundation

Krina Patel, MD, MSc
The University of Texas
MD Anderson Cancer Center

Satellite Symposia:
Practical Aspects of Incorporating CAR T-Cell Therapy into Your Practice

June 23, 2021 – Virtual
Time: 7 PM – 9:00 PM EDT

This live-streamed independent satellite symposium will take place following the #ASCO21 meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the use of CAR T-cell therapies for patients with lymphoma and multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summary of the symposium’s take-home messages most relevant to practice and clinical decision making.

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Satellite Symposia:
Practical Aspects of Incorporating CAR T-Cell Therapy into Your Practice

June 23, 2021 – Virtual
Time: 7:00 PM – 9:00 PM EDT

This live-streamed independent satellite symposium will take place following the #ASCO21 meeting and will be presented on an interactive web platform by 3 renowned experts actively engaged in the use of CAR T-cell therapies for patients with lymphoma and multiple myeloma.

Be sure to check back in July to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summary of the symposium’s take-home messages most relevant to practice and clinical decision making.

Click the Learn More button below to see the expert presenters and the agenda
There are no fees to register for this symposium

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Virtual Challenging Case Clinic™:
Discussions Between Community-Based Clinicians and Experts

Our Virtual Challenging Case Clinic™ is an interactive webinar series held monthly or bimonthly in select therapeutic disease areas. Similar to a virtual tumor board, each Virtual Challenging Case Clinic™ aims to link community-based clinicians with disease state experts to obtain clinical recommendations and discuss how to address challenging cases. You will engage with experts as they go through particularly challenging cases planned by various faculty – or submit your own challenging case for an open discussion.

"Very good discussion. Brief and straight to the point with good background data. Thanks for this."

B-Cell Lymphoma Virtual Challenging Case Clinic Attendee

Current Clinics

Recent Clinics

Current Clinics

Recent Clinics

Virtual Challenging Case Clinic™:
Discussions Between Community-Based Clinicians and Experts

Our Virtual Challenging Case Clinic™ is an interactive webinar series held monthly or bimonthly in select therapeutic disease areas. Similar to a virtual tumor board, each Virtual Challenging Case Clinic™ aims to link community-based clinicians with disease state experts to obtain clinical recommendations and discuss how to address challenging cases. You will engage with experts as they go through particularly challenging cases planned by various faculty – or submit your own challenging case for an open discussion.

"Very good discussion. Brief and straight to the point with good background data. Thanks for this."

B-Cell Lymphoma Virtual Challenging Case Clinic Attendee

Addressing Disparities in Cancer Care:
Incorporating Precision Medicine for Minority Populations Webinar Series

Endorsed by:
Addressing Disparities in Cancer Care for Minority Populations is a monthly webinar series that links community-based physicians with cancer experts to obtain clinical recommendations that address racial disparities in the treatment of cancer. Launching February 2021, this webinar series features experts who explore potential mechanisms and motivations underlying these differences. Identifying patient and healthcare system factors that may account for persistent racial disparities in cancer care is also a focus.

Topics

Addressing Disparities in Cancer Care:
Incorporating Precision Medicine for Minority Populations Webinar Series

Endorsed by:
Addressing Disparities in Cancer Care for Minority Populations is a monthly webinar series that links community-based physicians with cancer experts to obtain clinical recommendations that address racial disparities in the treatment of cancer. Launching February 2021, this webinar series features experts who explore potential mechanisms and motivations underlying these differences. Identifying patient and healthcare system factors that may account for persistent racial disparities in cancer care is also a focus.

Topics

"I really enjoyed the patient perspective. What an awesome panel of expert speakers. Can’t imagine any better. Great job!"

-Ovarian Nurse Practitioner

Satellite Symposia:
An Interactive Symposium at Major Oncology Congresses

Satellite Symposia offer multiple formats to choose from, depending on what you are looking for. Whether it be engaging with key experts in the field as they debate the latest data and treatment practices or hearing the patient’s perspective directly through case-based discussions, Satellite Symposia were created to give you a comprehensive presentation on a particular disease state. Regardless of which one you choose, your interactivity with experts will always be at the forefront through engaging and informative Q&A sessions.  

Previous Satellite Symposia

Satellite Symposia:
An Interactive Symposium at Major Oncology Congresses

Satellite Symposia offer multiple formats to choose from, depending on what you are looking for. Whether it be engaging with key experts in the field as they debate the latest data and treatment practices or hearing the patient’s perspective directly through case-based discussions, Satellite Symposia were created to give you a comprehensive presentation on a particular disease state. Regardless of which one you choose, your interactivity with experts will always be at the forefront through engaging and informative Q&A sessions.  

"I really enjoyed the patient perspective. What an awesome panel of expert speakers. Can’t imagine any better. Great job!"

-Ovarian Nurse Practitioner

Previous Satellite Symposia